$VPHM News Morgan Stanley drops Google from best idea

New Post Public Reply Private Reply Replies (0) Message Board

Nov 22, 2013 at 5:55 PM

$VPHM News

Morgan Stanley drops Google from best idea list 4:25 p.m. Nov. 11, 2013 - Sue Chang
Shire up in London; BSkyB, ITV off after BT soccer deal 12:10 p.m. Nov. 11, 2013 - Sara Sjolin
Strong Chinese data lift European markets 12:09 p.m. Nov. 11, 2013 - Sara Sjolin
Stock futures higher; Twitter, ViroPhama in spotlight 7:54 a.m. Nov. 11, 2013 - Barbara Kollmeyer
ViroPharma surges 26.5% premarket on Shire buyout 7:27 a.m. Nov. 11, 2013 - Ben Eisen
Shire pays $4.2B for rare-disease firm ViroPharma 2:54 a.m. Nov. 11, 2013 - MarketWatch.com
Powerful market uptrend meets seasonal tailwind 11:11 a.m. Nov. 1, 2013 - Michael Ashbaugh
ViroPharma shares soar on news of interest from two overseas buyers 5:09 p.m. Sept. 13, 2013 - Russ Britt
S&P 500 retests its one-decade breakout point 10:37 a.m. June 24, 2013 - Michael Ashbaugh
ViroPharma soars on buyout rumors 1:27 p.m. June 17, 2013 - Russ Britt
Market post-mortem: Big biotechs spike as Street warming to firms 4:43 p.m. April 12, 2013 - Russ Britt
Blood disease medication earns ViroPharma upbeat analyst reviews 12:43 p.m. March 27, 2013 - Russ Britt
Ratings hit three health firms; upgrade helps one 6:12 p.m. Jan. 15, 2013 - Russ Britt
Friday’s biggest gaining and declining stocks 3:14 p.m. Sept. 21, 2012 - Greg Morcroft
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
ViroPharma up 15% on FDA nod 2:25 p.m. Aug. 6, 2012 - Val Brickates Kennedy
ViroPharma has FDA nod to expand Cinryze 1:19 p.m. Aug. 6, 2012 - MarketWatch.com
Knight Capital, E-Trade options volumes soar 10:06 a.m. Aug. 2, 2012 - blogs.marketwatch.com

Shire Bolstering Its Rare Diseases Business 5:08 p.m. Nov. 20, 2013 - Investors Business Daily
Biotech Stock Roundup: Vanda Soars, Sarepta Slumps - Analyst Blog 11:33 a.m. Nov. 20, 2013 - Zacks.com
UPDATE: Stifel Downgrades ViroPharma Following News of Proposed Acquisition by Shire Pharmaceuticals 8:19 a.m. Nov. 19, 2013 - benzinga.com
Medicines Co. Gains on QIDP Status - Analyst Blog 1:10 p.m. Nov. 14, 2013 - Zacks.com
Shire PLC Makes For A Promising Investment 12:52 p.m. Nov. 13, 2013 - Seeking Alpha
Shire to Acquire ViroPharma - Analyst Blog 3:53 p.m. Nov. 12, 2013 - Zacks.com
Shire Acquires Viropharma: Two Winners In This Deal 12:55 p.m. Nov. 12, 2013 - Seeking Alpha
Stock Market News for November 12, 2013 - Market News 10:06 a.m. Nov. 12, 2013 - Zacks.com
UPDATE: J.P. Morgan Downgrades ViroPharma Following Announcement of Acquisition by Shire 9:40 a.m. Nov. 12, 2013 - benzinga.com
Benzinga's M&A Chatter for Monday November 11, 2013 5:31 p.m. Nov. 11, 2013 - benzinga.com
ViroPharma Larger Than S&P 500 Component JDS Uniphase 4:39 p.m. Nov. 11, 2013 - TheStreet.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Intel Buys ‘Kno’ to Reinforce Education Laptops Sideline and 2 Other Hot Stocks to Watch 11:35 a.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Shire's Growth Carries Swollen Price Tag 11:27 a.m. Nov. 11, 2013 - WSJ.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
Mid-Morning Market Update: Markets Edge Higher; Shire To Acquire ViroPharma For $4.2B 9:37 a.m. Nov. 11, 2013 - benzinga.com
Shire Shells Out $4.2B to Buy ViroPharma 9:15 a.m. Nov. 11, 2013 - FOXBusiness
Morning Market Movers 9:11 a.m. Nov. 11, 2013 - benzinga.com
Shire Buys ViroPharma for $4.2 Billion 8:02 a.m. Nov. 11, 2013 - WSJ.com

Study Results, Private Placements, Collaborations, Product Launches, and Public Offerings - Research Report on ViroPharma, Incyte, Tenet Healthcare, Sagent Pharmaceuticals and Chelsea Therapeutics 8:00 a.m. Today - PR Newswire
Morgan & Morgan Announces the Investigation of ViroPharma Incorporated 10:49 a.m. Nov. 21, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. 6:14 p.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of ViroPharma Incorporated Stockholders 5:11 p.m. Nov. 13, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of ViroPharma, Inc. - VPHM 3:15 p.m. Nov. 13, 2013 - PR Newswire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:57 a.m. Nov. 13, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. - VPHM 8:28 p.m. Nov. 12, 2013 - PR Newswire
Attention VPHM Shareholders: The Proposed Buyout of ViroPharma Incorporated by Shire plc is under Investigation by The Young Law Firm 1:00 p.m. Nov. 12, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 12:53 p.m. Nov. 12, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of ViroPharma Inc. 10:49 a.m. Nov. 12, 2013 - PR Newswire
FDA Updates, Corporate Developments: Viropharma, 3D Systems Corporation, Cirrus Logic, Zalicus, The Boeing Company 8:53 a.m. Nov. 12, 2013 - PR Newswire
Analysis of Pivotal Study Data Showed Routine Prevention of Hereditary Angioedema (HAE) Attacks with Cinryze® (C1 esterase inhibitor [human]) Resulted in Improved Health-Related Quality of Life Outcomes Compared to Acute Therapy with C1 Inhibitor While On Placebo 8:00 a.m. Nov. 12, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of ViroPharma, Inc. 5:24 p.m. Nov. 11, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation of Possible Breaches of Fiduciary Duty by Directors of ViroPharma Incorporated in Connection with Proposed Buyout 4:09 p.m. Nov. 11, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of ViroPharma Inc. Buyout Proposal 3:23 p.m. Nov. 11, 2013 - BusinessWire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2:33 p.m. Nov. 11, 2013 - BusinessWire
ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Shire 12:17 p.m. Nov. 11, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 11:15 a.m. Nov. 11, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Protecting Teeth: Insights from Endodontist Dr. Joubert

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...